Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayandip Mukherjee

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factorsNicole M Kane, Ali Nowrouzi, Sayandip Mukherjee, et al.
Cellular Reprogramming|August 28, 2014
Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobankingCaterina Pipino, Sayandip Mukherjee, Anna L David, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approachDafni Moschidou, Sayandip Mukherjee, Michael P Blundell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2024
Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free ApproachDafni Moschidou, Sayandip Mukherjee, Michael P Blundell, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factorsNicole M Kane, Ali Nowrouzi, Sayandip Mukherjee, et al.
Cellular Reprogramming|August 28, 2014
Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobankingCaterina Pipino, Sayandip Mukherjee, Anna L David, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approachDafni Moschidou, Sayandip Mukherjee, Michael P Blundell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2024
Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free ApproachDafni Moschidou, Sayandip Mukherjee, Michael P Blundell, et al.
Pageof 3